Applied Sciences
| Open Access |
DOI: OPTIMIZATION OF THE TECHNOLOGY OF “PHOSFARGININE SUCCINATE” INFUSION SOLUTION
V.R. Khaydarov , Candidate Of Pharmaceutical Sciences, Professor Of The Department Of Industrial Technology Of Medicines Tashkent Pharmaceutical Institute, Uzbekistan N.S. Fayzullaeva , Candidate Of Pharmaceutical Sciences, Associate Professor Of The Department Of Technology Of Dosage Forms Tashkent Pharmaceutical Institute, Uzbekistan F.Kh.Maksudova , Doctor Of Pharmacy (Dsc), Associate Professor Of The Department Of Industrial Technology Of Medicines Tashkent Pharmaceutical Institute, Uzbekistan Sh.B. Yusupova , Assistant Of The Department Of Industrial Technology Of Medicines Tashkent Pharmaceutical Institute, UzbekistanAbstract
In recent years, much attention has been paid to providing the population with domestically produced pharmaceuticals, the production of new import-substituting drugs that are affordable from an economic point of view, important tasks have been identified for “the development of the pharmaceutical industry, as well as improving the provision of the population and medical institutions with cheap, high-quality drugs”. In this regard, the search for new drugs, their introduction into the pharmaceutical industry is being carried out. One of these drugs is "Phosfarginine succinate" (consisting of D-fructose-1,6-diphosphate trisodium salt, L-arginine hydrochloride, succinic acid) infusion solution - a drug that stimulates and regulates the metabolic process. The infusion solution technology was developed on the basis of Temur Med Farm LLC (Republic of Uzbekistan). In order to select a scientifically based composition, develop and optimize the technological process, the method of mathematical planning of the experiment was used - Latin plans. The application of the method of mathematical planning of the experiment made it possible to select the optimal composition and technology of the infusion solution “Phosfarginine succinate”.
Keywords
cardiovascular diseases, Phosfarginine succinate
References
Bezverkhov A.A., Ishchenko O.Yu. Dynamics of mortality from cardiovascular diseases for the period 2015-2019//Norwegian Journal of development of the Internqtional Science.-№54.-2021.- pp. 35-38.
Meeting on medicine on mortality of the population of the Republic of Uzbekistan from cardiovascular diseases. - Tashkent, March 2022. [upl.uz›obshestvo/22347-news.html]
Vidal's Handbook.- M.: Vidal Rus.- 2021.- 1120 p. ISBN9785604443828.
State Register. Medicines, medical devices and medical equipment approved for use in medical practice.- Ed. No. 25, revised and supplemented, as of January 2021 - Tashkent, 2021.- 1067 p.
Kovalskaya G.N. Drug assistance: combined infusion pharmacotherapy. / G.N. Kovalskaya / New Pharmacy. - 2004. - No. 10. - pp. 25-36.
Mashkovsky, M D. Medicines. In two volumes. Ed. 15th / M. D. Mashkovsky. - M. "New Wave". - 2005. - 1200 p.
Yusupova Sh.B., Abdunazarov A.I., Khaidarov V.R., Kasimov E.R. Study of the specific activity of the drug “Phosfarginine succinate” solution for infusions//Infection, immunity and pharmacology.-№1.- 2022. pp. 327-331.
Yusupova Sh.B., Khaidarov V.R., Abdunazarov A.I. Inyektsion eritmalar. Phosforginine succinate va PC amantadin infuzion eritmalarini ishlab chikarish technologysi.-Monograph.-Tashkent: "Iqtisodiyot", 2020. - p.125.
Groshovii T.A., Markova E. V., Golovkin V.A. mathematical planning of experiment in pharmaceutical technology. Plans for analysis of variance. - Kyiv: High school, 1992. - 187 p.
International Pharmacopoeia. 4th ed. T.1. General methods of analysis. World Health Organization. - Geneva. 1981. – 242 p.
Kuzmina, Yu.A. A new method for quality control of electrolyte infusion solutions / Yu.A. Kuzmina, L.I. Gromova // Young scientists for practical health care: Sat. scientific tr. St. Petersburg, 2007. - p. 93.
State Pharmacopoeia XI ed., issue. 1. - M.:-1987.- pp. 266-286.
State Pharmacopoeia XI ed., issue. 2.-M.:-1990. - P.193.
Tsyrkunov V. M., Lazarevich S. N., Goncharov V. V. Antioxidant agents, a necessary component of complex pharmacotherapy // Prescription. - 2008. - No. 1.- pp. 69-74.
Article Statistics
Downloads
Copyright License
Copyright (c) 2022 The American Journal of Applied Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.